Ekso Bionics (NASDAQ: EKSO) reported Q1 EPS of ($0.20), $0.13 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $3.76 million versus the consensus estimate of $5.3 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.